MHRA Class 4 Medicines Defect Information: Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets
Class 4 Medicines Defect Information: Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets (Accord) Drug alert number: EL (22)A/35 Date issued: 17 August 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Rosuvastatin 5 mg film-coated tablets PL 20075/0402 Batch Number Expiry Date [...]
The post MHRA Class 4 Medicines Defect Information: Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets appeared first on PSNC Website.
Recent Comments